UnitedHealthcare Covers CNS Cancer Cerebrospinal Fluid Assay
The laboratory-developed test is used to detect and monitor metastatic central nervous system cancer.
The laboratory-developed test is used to detect and monitor metastatic central nervous system cancer.
A study on neuroblastoma with bone or bone marrow metastasis (NB-BBM) used deep learning to uncover biomarkers.
Mission Bio's collaboration will leverage single-cell DNA analysis for insights into multiple myeloma relapse and treatment strategies.
ClearNote’s ovarian cancer test has been issued a new CPT code by the AMA and preliminary reimbursement rate determinations from CMS.
Read MoreA new automated device can diagnose glioblastoma in under an hour using a novel electrokinetic biochip that detects active EGFRs from blood.
Read MoreLucid Diagnostics announced the peer-reviewed publication of an analytical validation study for its EsoGuard Esophageal DNA test.
Read MoreCancer Check Labs has been chosen as the exclusive provider of early cancer detection tests for Ways2Well, a regenerative medicine clinic.
Read MoreResearchers are developing a mouthwash-based test to detect biomarkers that may help predict the recurrence of head and neck cancer.
Read MoreThermo Fisher’s SeCore CDx HLA A Sequencing System received FDA clearance as a CDx for TECELRA, a T-cell receptor therapy from Adaptimmune.
Read MoreA blood test measuring lymphocyte levels may predict the effectiveness of CAR-T immunotherapy in relapsed multiple myeloma patients.
Read MoreA new machine-learning serum fusion-gene model shows promise in increasing hepatocellular carcinoma diagnostic accuracy and monitoring.
Read MoreResearcher identified a 15-gene signature biomarker that can stratify renal cancer patients into low or high risk of recurrence.
Read MoreA new genotyping test using cerebrospinal fluid can rapidly diagnose brain cancers, reducing the need for invasive biopsies.
Read MoreResearchers discovered a novel immune-based biomarker that could pave the way for potential early detection of high-grade ovarian cancer.
Read MoreA clinical trial shows that a Helio Genomics test outperforms ultrasound in detecting hepatocellular carcinoma in liver cirrhosis patients.
Read MoreSalignostics has partnered with ARC Innovation at Sheba Medical Center to develop a saliva-based test for detecting oral cavity cancer.
Read MoreMercy BioAnalytics will present data showing that their Mercy Halo test significantly improves early detection of ovarian cancer.
Read MoreResearchers discovered new biomarkers for renal cell carcinomas, enhancing the diagnosis of various subtypes.
Read More